These papers include general research about Mpox, such as Mpox vaccines, their effectiveness, their impact, safety, reduction in disease, morbidity and mortality, immunogenicity.
3 databases were used :
Google Scholar, PubMed, EbscoHost (Academic Search Premier, Africa-Wide Information, CINAHL, Health Source - Consumer Edition, Health Source - Nursing/Academic Edition, MEDLINE, APA PsycArticles, APA PsycInfo)
Acharya, A., Kumar, N., Singh, K., & Byrareddy, S. N. (2024). Mpox in MSM: Tackling Stigma, Minimizing Risk Factors, Exploring Pathogenesis, and Treatment Approaches. Biomedical Journal, 100746.
Adetifa, I., Muyembe, J.-J., Bausch, D. G., & Heymann, D. L. (2023). Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world. The lancet, 401(10390), 1822-1824. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154003/pdf/main.pdf
Adnyana, I. M. D. M., Eljatin, D. S., Maulana, S., Ibrahim, K., Umar, T. P., Armini, L. N., & da Cruz, Z. V. (2024). Mpox, HIV Infection, and Genital Skin Disease: Triple Burden, Threats and Challenges from an Epidemiological Perspective. SVĀSTHYA: Trends in General Medicine and Public Health, 1(1), e1-e1.
Alcamí, A. (2023). Pathogenesis of the circulating mpox virus and its adaptation to humans. Proceedings of the National Academy of Sciences, 120(13), e2301662120. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068839/pdf/pnas.202301662.pdf
Ali, Y.; Siddig, E. E.; Osman, M.; Mohamed, N. S.; Musa, A.; Ahmed, A. Preparedness, Prevention, Investigation, and Response to the Emergence of Mpox in Khartoum, Sudan in 2022. Preprints 2024, 2024060168. https://doi.org/10.20944/preprints202406.0168.v1
Alissa, M., Alghamdi, A., & Alghamdi, S. A. (2024). Overview of reemerging mpox infection with a focus on neurological manifestations. Reviews in medical virology, 34(2), e2527.
Allan-Blitz, L.-T., Khan, T., Elangovan, K., Smith, K., Multani, A., & Mayer, K. H. (2024). Addressing mpox at a Frontline Community Health Center: Lessons for the Next Outbreak. Public Health Reports, 139(3), 294-300.
Anjorin, A.-A. A., Odetokun, I. A., Ashaka, O. S., Fadipe, T. O., Muhammad, A., Sogbanmu, T. O., Nyandwi, J. B., Morakinyo, O. M., Dauda, A. B., & Adetona, M. A. (2023). Critical Appraisal of Mpox (Monkeypox) in Africa using Scoping and Systematic Reviews: Epidemiology, Biochemistry, Phylogeny, Pathogenesis, Clinical Features, Diagnosis, Treatment, Biosecurity and One-Health.
Atoui, A., Jourdain, F., Mouly, D., Cordevant, C., Chesnot, T., & Gassilloud, B. (2023). A review on mpox (monkeypox) virus shedding in wastewater and its persistence evaluation in environmental samples. Case Studies in Chemical and Environmental Engineering, 7, 100315.
Bourner, J., Garcia-Gallo, E., Mbrenga, F., Boum, Y., Nakouné, E., Paterson, A., ... & Rojek, A. (2024). Challenges in clinical diagnosis of Clade I Mpox: Highlighting the need for enhanced diagnostic approaches. PLOS Neglected Tropical Diseases, 18(6), e0012087. https://doi.org/10.1371/journal.pntd.0012087
Bragazzi, N. L., Iyaniwura, S. A., Han, Q., Woldegerima, W. A., & Kong, J. D. (2024). Quantifying the basic reproduction number and underestimated fraction of Mpox cases worldwide at the onset of the outbreak. Journal of the Royal Society Interface, 21(216), 20230637. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267235/pdf/rsif.2023.0637.pdf
Bragazzi, N. L., Woldegerima, W. A., Wu, J., Converti, M., Szarpak, L., Crapanzano, A., Odeh, M., Farah, R., & Khamisy-Farah, R. (2024). Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to the Female Sex at Birth: A Comprehensive, Critical Global Perspective. Viruses, 16(3), 325. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976245/pdf/viruses-16-00325.pdf
Branda, F., Romano, C., Ciccozzi, M., Giovanetti, M., Scarpa, F., Ciccozzi, A., & Maruotti, A. (2024). Mpox: An Overview of Pathogenesis, Diagnosis, and Public Health Implications. Journal of Clinical Medicine, 13(8), 2234. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11050819/pdf/jcm-13-02234.pdf
Cohen, J. (2024). Africa steps up battle against mpox outbreaks. Science (New York, NY), 384(6694), 373-374.
El Dine, F. B., Gebreal, A., Samhouri, D., Estifanos, H., Kourampi, I., Abdelrhem, H., Mostafa, H. A. a., Elshaar, A. G., Suvvari, T. K., & Ghazy, R. M. (2024). Ethical considerations during Mpox Outbreak: a scoping review. BMC Medical Ethics, 25(1), 79. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265031/pdf/12910_2024_Article_1078.pdf
Eslami, A., Alimoghadam, S., Khoshravesh, S., Shirani, M., Alimoghadam, R., & Alavi Darazam, I. (2024). Mpox vaccination and treatment: a systematic review (Africa). Journal of Chemotherapy, 36(2), 85-109.
Gallo, P., Galea, N., Colucci, A., Valli, R., Schwarz, M., Belasio, E. F., d’Ari, A., Furiozzi, F., Caraglia, A., & Dalla Torre, R. (2024). Mpox: Awareness, knowledge and information channels used by individuals accessing a sexually transmitted infections Helpline. (Africa) Annali di Igiene: Medicina Preventiva e di Comunita.
Gao, L., Shi, Q., Dong, X., Wang, M., Liu, Z., & Li, Z. (2023). Mpox, Caused by the MPXV of the Clade IIb lineage, goes global. Tropical Medicine and Infectious Disease, 8(2), 76. (Africa) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966881/pdf/tropicalmed-08-00076.pdf
Ghosn, J., Assoumou, L., Ouattara, M., Rubenstein, E., Pialoux, G., Katlama, C., Surgers, L., Duvivier, C., Pavie, J., & Viard, J.-P. (2024). Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial. The Lancet Regional Health–Europe, 45.
Halwani, M. A. (2024). Endemic Cross-transmission of Mpox within Health-care Settings: A Comprehensive Review (Africa). Hail Journal of Health Sciences, 6(1), 9-18.
Haque, M. A., Halder, A. S., Hossain, M. J., & Islam, M. R. (2024). Prediction of potential public health risk of the recent multicountry monkeypox outbreak: An update after the end declaration of global public health emergency. Health Science Reports, 7(6), e2136. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136639/pdf/HSR2-7-e2136.pdf
Ibrahim, O. O. Introduction to Monkeypox (MPOX) Virus Infection, Symptoms and Treatments (Africa).
Jiang, W., Hu, Y., Yang, X., Hou, L., Zhang, J., Niu, H., Hu, C., & Lin, J. (2024). Breakthrough infection and reinfection in patients with mpox. Reviews in medical virology, 34(2), e2522.
Kang, Y., & Ahmad, S. (2023). The emerging epidemics in recent: mpox. Life Cycle, 3.
Karagoz, A., Tombuloglu, H., Alsaeed, M., Tombuloglu, G., AlRubaish, A. A., Mahmoud, A., Smajlović, S., Ćordić, S., Rabaan, A. A., & Alsuhaimi, E. (2023). Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. Journal of infection and public health, 16(4), 531-541. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908738/pdf/main.pdf
Khallafallah, O., & Grose, C. (2022). Reassessment of evidence about coinfection of chickenpox and monkeypox (mpox) in African children. Viruses, 14(12), 2800. https://doi.org/10.3390/v14122800
Klingelhöfer, D., Braun, M., Groneberg, D. A., & Brüggmann, D. (2023). Global mpox research in the light of the current outbreak: demands, drivers, and obstacles.(Africa) Emerging Microbes & Infections, 12(1), 2210696.
Komakech, A., Ajong, B. N., Kalala, D., Efire, N., Kacita, C., Vakaniaki, E. H., Izudi, J., Liesenborghs, L., & Ndembi, N. (2024). Africa should research the long-term sequelae of mpox. The Lancet Global Health.
Kozlov, M. (2023). MPOX OUTBREAK WANES GLOBALLY—BUT RAGES ON IN AFRICA.
Kurra, S. (2024). Mpox Vaccines.
Laurenson-Schafer, H., Sklenovská, N., Hoxha, A., Kerr, S. M., Ndumbi, P., Fitzner, J., Almiron, M., de Sousa, L. A., Briand, S., & Cenciarelli, O. (2023). Description of the first global outbreak of mpox: an analysis of global surveillance data. (Africa) The Lancet Global Health, 11(7), e1012-e1023. https://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(23)00198-5.pdf
Li, P., Li, J., Ayada, I., Avan, A., Zheng, Q., Peppelenbosch, M. P., de Vries, A. C., & Pan, Q. (2023). Clinical features, antiviral treatment, and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks. The Journal of Infectious Diseases, 228(4), 391-401. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428207/pdf/jiad034.pdf
Li, T., Li, Z., Xia, Y., Long, J., & Qi, L. (2024). Mpox reinfection: A rapid systematic review of case reports. Infectious Medicine, 3(1), 100096. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10998266/pdf/main.pdf
Liu, H., Wang, W., Zhang, Y., Wang, F., Duan, J., Huang, T., Huang, X., & Zhang, T. (2024). Global Perspectives on Smallpox Vaccine against Monkeypox: A Comprehensive Meta-Analysis and Systematic Review of Effectiveness, Protection, Safety and Cross-immunogenicity. Emerging Microbes & Infections(just-accepted), 2387442.
Malik, S., Ahmad, T., Ahsan, O., Muhammad, K., & Waheed, Y. (2023). Recent developments in mpox prevention and treatment options. Vaccines, 11(3), 500. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057056/pdf/vaccines-11-00500.pdf
Manirambona, E., Khan, S. H., Siddiq, A., Albakri, K., Salamah, H. M., Hassan, N. A. I. F., Musa, S. S., & Dhama, K. (2024). Intriguing insight into unanswered questions about Mpox: exploring health policy implications and considerations. Health research policy and systems, 22(1), 37 7 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10960492/pdf/12961_2024_Article_1123.pdf
Mason, L. M. K., Betancur, E., Riera-Montes, M., Lienert, F., & Scheele, S. (2024). MVA-BN Vaccine Effectiveness: A Systematic Review of Real-World Evidence in Outbreak Settings. medRxiv, 2024.2004. 2025.24306078.
McCabe, R., Johnson, L. F., & Whittles, L. K. (2024). Estimating the burden of mpox among MSM in South Africa. medRxiv, 2024-08.
Mektebi, A., Elsaid, M., Yadav, T., Abdallh, F., Assker, M., Siddiq, A., Sayad, R., Saifi, M., & Farahat, R. A. (2024). Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis. BMC public health, 24(1), 4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10759337/pdf/12889_2023_Article_17186.pdf
Mercy, K., Tibebu, B., Fallah, M., Faria, N. R., Ndembi, N., & Tebeje, Y. K. (2024). Mpox continues to spread in Africa and threatens global health security. Nature Medicine, 30(5), 1225-1226. https://www.nature.com/articles/s41591-024-02862-6
Mohapatra, R. K., Singh, P. K., Branda, F., Mishra, S., Kutikuppala, L. S., Suvvari, T. K., Kandi, V., Ansari, A., Desai, D. N., & Alfaresi, M. (2024). Transmission dynamics, complications and mitigation strategies of the current mpox outbreak: A comprehensive review with bibliometric study. Reviews in medical virology, 34(3), e2541.
Musuka, G., Moyo, E., Tungwarara, N., Mhango, M., Pierre, G., Saramba, E., Iradukunda, P. G., & Dzinamarira, T. (2024). A Critical Review of Mpox Outbreaks, Risk Factors, and Prevention Efforts in Africa: Lessons Learned and Evolving Practices. IJID Regions, 100402.
Nachega, J. B., Sam-Agudu, N. A., Ogoina, D., Mbala-Kingebeni, P., Ntoumi, F., Nakouné, E., Njouom, R., Lewis, R. F., Gandhi, M., & Rosenthal, P. J. (2024). The surge of mpox in Africa: a call for action. The Lancet Global Health. DOI:https://doi.org/10.1016/S2214-109X(24)00187-6
Norberg, A. N., Norberg, P. R. B. M., Manhães, F. C., Souza, D. G. d., Queiroz, M. M. d. C., Neto, C. H. G., Ribeiro, P. C., Boechat, J. C. d. S., Viana, K. S., & Silva, M. T. R. d. (2024). Public Health Strategies Against Social Stigma in the Mpox Outbreak: A Systematic Review. Journal of Advances in Medicine and Medical Research, 36(2), 33-47.
Núñez‐Cortés, R., Calatayud, J., López‐Gil, J. F., Koyanagi, A., Casana, J., & López‐Bueno, R. (2023). Risk profile and mode of transmission of Mpox: a rapid review and individual patient data meta‐analysis of case studies. Reviews in medical virology, 33(2), e2410. https://doi.org/10.1002/rmv.2410
Ogliastro, M., Ferrari, A., Sticchi, L., Domnich, A., Zappa, G., Di Biagio, A., Massaro, E., Giribaldi, E., & Orsi, A. (2024). Effectiveness of a Counseling Intervention to Increase Vaccination Uptake among Men Who Have Sex with Men during the Mpox Outbreak. Vaccines, 12(7).
Ogoina, D., Damon, I., & Nakoune, E. (2023). Clinical review of human mpox (Africa). Clinical Microbiology and Infection.
Olliaro, P., Bourner, J., Boum II, Y., Nakouné, E., Pesonel, E., Rojek, A., ... & Dunning, J. (2024). Mpox: The alarm went off. Have we gone back to sleep?. PLOS Neglected Tropical Diseases, 18(1), e0011871. https://doi.org/10.1371/journal.pntd.0011871
Pischel, L., Martini, B. A., Yu, N., Cacesse, D., Tracy, M., Kharbanda, K., Ahmed, N., Patel, K. M., Grimshaw, A. A., & Malik, A. A. (2024). Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis. Vaccine.
Pitcock, C. T., Van Sickels, N., & Romanelli, F. (2024). Advances in recognizing, treating, and preventing mpox infection. JAPhA Pharmacotherapy, 1(2).
Raccagni, A. R., Castagna, A., & Nozza, S. (2024). Detection of Mpox Virus in Seminal Fluids: Implications for Sexual Transmission. The new Microbiologica, 46(4), 317-321.
Ramírez-Soto, M. C., & Arroyo-Hernández, H. (2024). Monkeypox virus infections in low-risk groups during the 2022–23 global outbreak: An analysis of the WHO global report. Le Infezioni in Medicina, 32(1), 12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917560/pdf/1124-9390_32_1_2024_012-019.pdf
Saied, A. A. (2023). Mpox virus Clade IIb detection in the air. Journal of medical virology, 95(5), e28775.
Saloni, S., Soman, B., Tanti, A., Goyal, A. K., & Kumar, P. (2024). Global resurgence of monkeypox (mpox) virus: a review of current outbreaks and public health strategies. The Evidence, 2(3).
Selvaraj, N., Shyam, S., Dhurairaj, P., Thiruselvan, K., Thiruselvan, A., Kancherla, Y., & Kandamaran, P. (2023). Mpox: epidemiology, clinical manifestations and recent developments in treatment and prevention. Expert Review of Anti-infective Therapy, 21(6), 641-653.(Africa)
Siegrist, E. A., & Sassine, J. (2023). Antivirals with activity against mpox: a clinically oriented review. Clinical Infectious Diseases, 76(1), 155-164. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825831/pdf/ciac622.pdf
Subissi, L., Stefanelli, P., & Rezza, G. (2024). Human mpox: global trends, molecular epidemiology and options for vaccination. Pathogens and Global Health, 118(1), 25-32.
Sulaiman, S. K., Isma’il Tsiga-Ahmed, F., Musa, M. S., Makama, B. T., Sulaiman, A. K., & Abdulaziz, T. B. (2024). Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis. Communications Medicine, 4(1), 136. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231226/pdf/43856_2024_Article_564.pdf
Svecova, D. (2024). Update on Monkeypox Virus Infection. Journal of Medicine and Healthcare. SRC/JMHC-344. org/10.47363/JMHC/2024 (6), 274, 2-3.
Taylor, L. (2024). Mpox in Africa: WHO and Africa CDC consider declaring public health emergency as cases spike. In: British Medical Journal Publishing Group.
Thornhill, J., Gandhi, M., & Orkin, C. (2024). Mpox: The Reemergence of an Old Disease and Inequities. Annual Review of Medicine, 75(1), 159-175.
Ubom, A. E., Oiwoh, S. O., Ajiboye, A. D., Nyeche, S., Appiah‐Kubi, A., Sokunbi, A. E., Mbiiza, C. M., Olanrewaju, F. O., Ighorodje, E. E., & Akinkugbe, A. (2023). Mpox in pregnancy: Management, risks and challenges in Africa and lessons from the COVID‐19 pandemic. International Journal of Gynecology & Obstetrics, 163(2), 466-475.
Ulaeto, D., Agafonov, A., Burchfield, J., Carter, L., Happi, C., Jakob, R., Krpelanova, E., Kuppalli, K., Lefkowitz, E. J., & Mauldin, M. R. (2023). New nomenclature for mpox (monkeypox) and monkeypox virus clades. The Lancet Infectious Diseases, 23(3), 273-275. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901940/pdf/main.pdf
Wang, J., Nguyen, L., Volante, V., Daniel, J., & Preuss, C. (2024). Mpox: New Challenges with the Disease. Rising Contagious Diseases: Basics, Management, and Treatments, 20-30.
Wang, X., Gu, Z., Sheng, S., Song, R., & Jin, R. (2024). The Current State and Progress of Mpox Vaccine Research. China CDC Weekly, 6(7), 118. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10883320/pdf/ccdcw-6-7-118.pdf
Yu, X., Shi, H., & Cheng, G. (2023). Mpox virus: its molecular evolution and potential impact on viral epidemiology. (Africa). Viruses, 15(4), 995. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142743/pdf/viruses-15-00995.pdf
Yuqian, Z., Yize, H., Wenling, W., & Wenjie, T. (2024). Advancements in Mpox Vaccine Development: A Comprehensive Review of Global Progress and Recent Data. Biomedical and Environmental Sciences, 37, 1-7.
Angelo, K. M., Smith, T., Camprubí-Ferrer, D., Balerdi-Sarasola, L., Díaz Menéndez, M., Servera-Negre, G., Barkati, S., Duvignaud, A., Huber, K. L. B., Chakravarti, A., Bottieau, E., Greenaway, C., Grobusch, M. P., Mendes Pedro, D., Asgeirsson, H., Popescu, C. P., Martin, C., Licitra, C., de Frey, A., … Libman, M. (2023). Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: A cross-sectional study. The Lancet. Infectious Diseases, 23(2), 196–206. https://doi.org/10.1016/S1473-3099(22)00651-X
Cappelletti-Montano, B., Demuru, G., Laconi, E., & Musio, M. (2023). A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults. Frontiers in Public Health, 11, 1145645. https://doi.org/10.3389/fpubh.2023.1145645
Cardoso, M., Ragan, I., Hartson, L., & Goodrich, R. P. (2023). Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies. Pathogens (Basel, Switzerland), 12(7). https://doi.org/10.3390/pathogens12070911
Guzzetta, G., Marziano, V., Mammone, A., Siddu, A., Ferraro, F., Caraglia, A., Maraglino, F., Rezza, G., Vespignani, A., Longini, I., Ajelli, M., & Merler, S. (2024). The decline of the 2022 Italian mpox epidemic: Role of behavior changes and control strategies. Nature Communications, 15(1), 2283. https://doi.org/10.1038/s41467-024-46590-4
Harvala, H., & Simmonds, P. (2022). Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections. Transfusion Medicine, 32(6), 460–466.
Jia, Q., Xue, L., Sui, R., & Huo, J. (2024). Modelling the impact of human behavior using a two-layer Watts-Strogatz network for transmission and control of Mpox. BMC Infectious Diseases, 24(1), 1–13.
Liu, H., Wang, W., Zhang, Y., Wang, F., Duan, J., Huang, T., Huang, X., & Zhang, T. (2024). Global perspectives on smallpox vaccine against monkeypox: A comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity. Emerging Microbes & Infections, 13(1), 2387442. https://doi.org/10.1080/22221751.2024.2387442
Martín-Iguacel, R., Pericas, C., Bruguera, A., Rosell, G., Martínez, E., Díaz, Y., Alonso, L., Nomah, D. K., Blanco, J. L., Domingo, P., Álvarez-López, P., Linares, M. S., Vilades Laborda, C., Mera, A., Calzado Isbert, S., Johansen, I. S., Miró, J. M., Casabona, J., & Llibre, J. M. (2023). Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study. Microorganisms, 11(11). https://doi.org/10.3390/microorganisms11112701
Mazzotta, V., Lepri, A. C., Matusali, G., Cimini, E., Piselli, P., Aguglia, C., Lanini, S., Colavita, F., Notari, S., Oliva, A., Meschi, S., Casetti, R., Mondillo, V., Vergori, A., Bettini, A., Grassi, G., Pinnetti, C., Lapa, D., Tartaglia, E., … Antinori, A. (2024). Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: Prospective cohort study. EClinicalMedicine, 68, 102420. https://doi.org/10.1016/j.eclinm.2023.102420
Nam Joong Kim & Sun Huh. (2023). How to cope with suspected mpox patients in the outpatient clinic. Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 66(5), 325–333. https://doi.org/10.5124/jkma.2023.66.5.325
Raccagni, A. R., Castagna, A., & Nozza, S. (2024). Detection of Mpox Virus in Seminal Fluids: Implications for Sexual Transmission. The New Microbiologica, 46(4), 317–321.
Roper, R. L., Garzino-Demo, A., Del Rio, C., Bréchot, C., Gallo, R., Hall, W., Esparza, J., Reitz, M., Schinazi, R. F., Parrington, M., Tartaglia, J., Koopmans, M., Osorio, J., Nitsche, A., Huan, T. B., LeDuc, J., Gessain, A., Weaver, S., Mahalingam, S., & Abimiku, A. (2023). Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies. Vaccine, 41(20), 3171–3177.
Segeral, O., Musumeci, S., Kaiser, L., & Calmy, A. (2023). [Monkeypox: A new emerging infectious threat?]. Revue Medicale Suisse, 19(822), 702–707. https://doi.org/10.53738/REVMED.2023.19.822.702
Tran, B. X., Anh Do, L., Hoang, T. P., Boyer, L., Auquier, P., Fond, G., Le, H. T., Le Vu, M. N., Dang, T. H. T., Nguyen, A. H. T., Latkin, C. A., Ho, R. C., Ho, C. S., & Zhang, M. W. (2023). Crucial choices in a global health crisis: Revealing the demand and willingness to pay for a hypothetical monkeypox vaccine—The PREVENT study. Journal of Global Health, 13, 04033. https://doi.org/10.7189/jogh.13.04033
Wolff Sagy, Y., Zucker, R., Hammerman, A., Markovits, H., Arieh, N. G., Abu Ahmad, W., Battat, E., Ramot, N., Carmeli, G., Mark-Amir, A., Wagner-Kolasko, G., Duskin-Bitan, H., Yaron, S., Peretz, A., Arbel, R., Lavie, G., & Netzer, D. (2023). Real-world effectiveness of a single dose of mpox vaccine in males. Nature Medicine, 29(3), 748–752. https://doi.org/10.1038/s41591-023-02229-3
Dimitrov, D., Adamson, B., & Matrajt, L. (2023). Evaluation of mpox vaccine dose-sparing strategies. PNAS nexus, 2(5), pgad095. DOI: 10.1093/pnasnexus/pgad095
Ahmed, S. K., Dabou, E. A., Ibrahim, F. M., Mohammed, M. G., Chandran, D., Basit, J., Chakraborty, S., Emran, T. B., Islam, R., & Dhama, K. (2024). Challenges and Counteracting Strategies Including Optimum Health Service Practices for Frontline Nurses During the Mpox Outbreak and Futuristic Vision. SAGE open nursing, 10, 23779608241256209. DOI: 10.1177/23779608241256209
Ogliastro, M., Ferrari, A., Sticchi, L., Domnich, A., Zappa, G., Di Biagio, A., Massaro, E., Giribaldi, E., & Orsi, A. (2024). Effectiveness of a Counseling Intervention to Increase Vaccination Uptake among Men Who Have Sex with Men during the Mpox Outbreak. Vaccines, 12(7), 751. DOI: 10.3390/vaccines12070751
Fox, T., Gould, S., Princy, N., Rowland, T., Lutje, V., & Kuehn, R. (2023). Therapeutics for treating mpox in humans. The Cochrane database of systematic reviews, 3(3), CD015769. DOI: 10.1002/14651858.CD015769
Hughes, L., Wilkins, K., Goldsmith, C. S., Smith, S., Hudson, P., Patel, N., Karem, K., Damon, I., Li, Y., Olson, V. A., & Satheshkumar, P. S. (2017). A rapid Orthopoxvirus purification protocol suitable for high-containment laboratories. Journal of virological methods, 243, 68–73. DOI: 10.1016/j.jviromet.2017.01.018
Gul, I., Liu, C., Yuan, X., Du, Z., Zhai, S., Lei, Z., Chen, Q., Raheem, M. A., He, Q., Hu, Q., Xiao, C., Haihui, Z., Wang, R., Han, S., Du, K., Yu, D., Zhang, C. Y., & Qin, P. (2022). Current and Perspective Sensing Methods for Monkeypox Virus. Bioengineering (Basel, Switzerland), 9(10), 571. DOI: 10.3390/bioengineering9100571